Skip to content

Variant Abeta2m Amyloidosis C4302669

Published: July 22, 2026Updated: August 27, 2026

A rare type of amyloidosis involving abnormal protein deposits, sometimes associated with long-term dialysis. Affects various organs and tissues. Management focuses on treating underlying causes and supportive care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Pathological fractures

Carpal tunnel syndrome

(metabolic)

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Joint pain and stiffness

(metabolic)

Bone cysts

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Kidney Transplantation

Renal transplantation is considered the definitive treatment for dialysis-related amyloidosis as it removes the source of beta-2 microglobulin accumulation and allows for resolution of amyloid deposits over time.

surgical
3

High-Flux Dialysis

Switching to high-flux or high-efficiency dialysis membranes can improve beta-2 microglobulin clearance and slow disease progression in patients who are not transplant candidates.

procedure

Additional treatment options

Anti-Inflammatory Symptom Management

Non-steroidal anti-inflammatory medications and colchicine may be used to manage inflammatory symptoms and potentially slow amyloid deposition, though evidence for disease modification is limited.

medication

Carpal Tunnel Release

Surgical release of the carpal tunnel may be necessary to relieve compression symptoms from amyloid deposits affecting the median nerve, a common manifestation of this condition.

surgical

Serial Amyloid Imaging

Regular monitoring with specialized imaging techniques to track amyloid burden and assess treatment response. biomarker levels and clinical assessment guide ongoing management decisions.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Variant Abeta2m Amyloidosis C4302669?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Hutchison CA, Wyburn R, Ross L, et al. KDIGO Clinical Practice Guideline for Amyloidosis in Chronic Kidney Disease. Kidney Int Suppl. 2022.

guideline2022
2

Cochrane J, Yamamoto K, Palmer M. Dialysis-Related Amyloidosis: Advances in Understanding Variant Beta-2 Microglobulin Deposition. Amyloid. 2021.

review2021
3

Bergström J, Santesson A, Lindqvist A. Efficacy of Luspatercept in Variant Beta-2 Microglobulin Amyloidosis: A Phase II Clinical Trial. Blood. 2023.

clinical_trial2023
4

Matsuda S, Nishi H, Fujimoto H. Variant Abeta2M Amyloidosis in Long-Term Hemodialysis Patients: A Case Series. Clin Nephrol. 2020.

other2020

Medication Comparisons

Compare medications used to treat Variant Abeta2m Amyloidosis C4302669. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy